145 related articles for article (PubMed ID: 20165850)
1. iTRAQ-coupled 2D LC-MS/MS analysis of secreted proteome of HBV-replicating HepG2 cells: potential in biomarkers for prognosis of HCC.
Feng H; Wang M; Chen WN
Curr Microbiol; 2010 Oct; 61(4):280-4. PubMed ID: 20165850
[TBL] [Abstract][Full Text] [Related]
2. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
3. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
4. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
5. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.
Liu Y; Wang X; Li S; Hu H; Zhang D; Hu P; Yang Y; Ren H
J Proteomics; 2014 Jun; 106():99-112. PubMed ID: 24769235
[TBL] [Abstract][Full Text] [Related]
6. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
Niu D; Feng H; Chen WN
J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS.
Zhao X; Wu Y; Duan J; Ma Y; Shen Z; Wei L; Cui X; Zhang J; Xie Y; Liu J
J Proteome Res; 2014 Dec; 13(12):5391-402. PubMed ID: 25265333
[TBL] [Abstract][Full Text] [Related]
9. Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS/MS analysis.
Feng H; Li X; Niu D; Chen WN
J Proteomics; 2010 Jun; 73(8):1421-32. PubMed ID: 20026004
[TBL] [Abstract][Full Text] [Related]
10. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
[TBL] [Abstract][Full Text] [Related]
11. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.
She S; Yang M; Hu H; Hu P; Yang Y; Ren H
Cell Physiol Biochem; 2018; 45(2):744-760. PubMed ID: 29414802
[TBL] [Abstract][Full Text] [Related]
12. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation.
Niu D; Sui J; Zhang J; Feng H; Chen WN
Proteomics; 2009 Aug; 9(15):3856-68. PubMed ID: 19639599
[TBL] [Abstract][Full Text] [Related]
14. Protein alteration of HepG2.2.15 cells induced by iron overload.
Fang C; Zhao C; Liu X; Yang P; Lu H
Proteomics; 2012 May; 12(9):1378-90. PubMed ID: 22589187
[TBL] [Abstract][Full Text] [Related]
15. Identification of p90 Ribosomal S6 Kinase 2 as a Novel Host Protein in HBx Augmenting HBV Replication by iTRAQ-Based Quantitative Comparative Proteomics.
Yan LB; Yu YJ; Zhang QB; Tang XQ; Bai L; Huang F; Tang H
Proteomics Clin Appl; 2018 May; 12(3):e1700090. PubMed ID: 29350888
[TBL] [Abstract][Full Text] [Related]
16. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
17. Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease.
Ye B; Shen Y; Chen H; Lin S; Mao W; Dong Y; Li X
Sci Rep; 2022 Aug; 12(1):14428. PubMed ID: 36002595
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
Yan SY; Fan JG; Qio L
Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
[TBL] [Abstract][Full Text] [Related]
19. High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial-mesenchymal transition.
Wang T; Jin Y; Zhao R; Wu Y; Zhang Y; Wu D; Kong D; Jin X; Zhang F
Int J Infect Dis; 2014 Mar; 20():37-41. PubMed ID: 24412602
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.
Lin YT; Jeng LB; Chan WL; Su IJ; Teng CF
Viruses; 2021 May; 13(5):. PubMed ID: 34066744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
